The Heparin Binding Motif of Endostatin Mediates Its Interaction with Receptor Nucleolin
- 17 November 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 48 (49) , 11655-11663
Abstract
Endostatin is a potent angiogenesis inhibitor with heparin-dependent activities. Nucleolin, a novel functional receptor of endostatin, mediates both the internalization to endothelial cells and the antiangiogenic activity of endostatin. To define the exact role of the heparin binding motif in mediating the interaction between endostatin and its receptor nucleolin, up to six arginine residues (R155, R158, R184, R270, R193, and R194) located in the heparin binding motif of endostatin were substituted by alanine to make double, quadruple, or hexad point mutations, respectively. Contributions of the heparin binding motif to both the interaction with nucleolin and the biological activities of endostatin were investigated from in vitro to in vivo. Here we show that Arg to Ala point mutagenesis of the heparin binding motif does not interrupt the folding of endostatin but significantly impairs the interaction between endostatin and nucleolin. Double and quadruple mutants showed significantly decreased internalization to endothelial cells and antitumor activities, while the hexad Arg to Ala mutant completely lost its interaction with nucleolin and biological functions. Taken together, the present study demonstrates that the arginine clusters in the heparin binding motif of endostatin significantly contribute to its interaction with receptor nucleolin and mediate the antiangiogenic and antitumor activities of endostatin.Keywords
This publication has 26 references indexed in Scilit:
- Endostatin finds a new partner: nucleolinBlood, 2007
- Endostatin competes with bFGF for binding to heparin-like glycosaminoglycansBiochemical and Biophysical Research Communications, 2005
- Contributions of Disulfide Bonds in a Nested Pattern to the Structure, Stability, and Biological Functions of EndostatinJournal of Biological Chemistry, 2005
- Endostatin's heparan sulfate-binding site is essential for inhibition of angiogenesis and enhances in situ binding to capillary-like structures in bone explantsMatrix Biology, 2005
- The Minimal Active Domain of Endostatin Is a Heparin-Binding Motif that Mediates Inhibition of Tumor VascularizationCancer Research, 2004
- Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vesselsJournal of Cell Biology, 2003
- Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated DailyJournal of Clinical Oncology, 2002
- Crystal structure of the angiogenesis inhibitor endostatin at 1.5 Å resolutionThe EMBO Journal, 1998
- HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell LineJournal of Investigative Dermatology, 1992
- Synergistic effect of histone H1 and nucleolin on chromatin condensation in mitosis: role of a phosphorylated heteromerBiochemistry, 1991